TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBOTT LABORATORIES Share Price

Certificat

DE000SW1FZ12

Delayed Deutsche Boerse AG 02:44:40 20/05/2024 pm IST
4.12 EUR -0.72% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBOTT LABORATORIES
Current month+3.23%
1 month+2.22%
Date Price Change
20/24/20 4.12 -0.72%
17/24/17 4.15 +1.47%
16/24/16 4.09 -0.73%
15/24/15 4.12 -1.90%
14/24/14 4.2 +1.69%

Delayed Quote Deutsche Boerse AG

Last update May 20, 2024 at 02:44 pm IST

More quotes

Static data

Product typeKnock-Out sin Stop Loss
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SW1FZ1
ISINDE000SW1FZ12
Date issued 25/07/2023
Strike 149 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.24
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 5.64
Lowest since issue 2.56
Spread 0.08
Spread %1.90%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.1 USD
Average target price
126.1 USD
Spread / Average Target
+21.19%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW